Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, and rely entirely on patients and healthy volunteers. Learn more about clinical trials at Novartis including opportunities to get involved.

Search for Novartis clinical trials that are currently recruiting participants.

A full listing of Novartis clinical trials which also includes active and completed studies can be found atClinicalTrials.gov.

Find recruiting trials

Novartis trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, and rely entirely on patients and healthy volunteers.

Learn more

Participating in a clinical trial

A patient asking a doctor about a clinical trial

For patients

Information for patients or caregivers interested in participating in a clinical trial
A doctor filling in a clinical trial medical chart

For healthcare professionals

Working with Novartis on clinical trials

Transparency

Our vision is to be a trusted leader in changing the practice of medicine. Novartis believes one aspect of building trust with society and research participants is through making our ongoing trials and their trial results public, regardless of the outcome of the trial.
Woman smiling at doctor

Clinical trial results

Novartis has long been dedicated to informing the public about interventional trial results. Novartis launched the results website in 2005 becoming one of the first companies to provide this information to the public.
A doctor talks to a heart patient

Trial summaries for patients

Trial summaries for patients are written in easier to understand language than the corresponding technical result summaries. Patients summaries are provided in English and local languages.
Patient using a tablet

Clinical trial data sharing

Novartis is committed to sharing with qualified external researchers, access to anonymized patient level data and clinical study reports from eligible studies.
Board room meeting

NARD (Novartis Anonymized Redacted Dossiers)

NARD is a publicly accessible website for Novartis to share dossiers submitted to Health Authorities for product approval in an anonymized/redacted format.
Learn more

Country resources

Germany
Switzerland
Explore the latest news on reimagining medicine